Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Upper Extremity Motor Function in Stroke Patients
Launched by LITHUANIAN UNIVERSITY OF HEALTH SCIENCES · Dec 2, 2022
Trial Information
Current as of January 14, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a treatment called repetitive transcranial magnetic stimulation (rTMS) on improving arm and hand movement in patients who have had a stroke. The researchers want to find out if rTMS can help people regain better control of their upper limbs and whether a specific type of stimulation, either low-frequency or high-frequency, works better than a fake (sham) treatment. Participants will undergo 10 sessions of rTMS over two weeks, and their ability to move their arms will be tested before treatment and again three to four weeks later.
To be eligible for this study, participants should have had a recent ischemic stroke affecting the middle part of the brain and experience some weakness or difficulty moving their hand. They should be within one month of the stroke and have no severe problems with thinking or understanding. However, those with certain medical devices, serious cognitive issues, or specific health conditions will not be able to join. This trial is currently looking for participants of all genders, aged 65-74, who want to explore new ways to improve their recovery after a stroke.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Ischemic stroke of the middle cerebral artery, confirmed by instrumental tests (CT, MRI).
- • 2. Acute hemiplegia/hemiparesis, hand motor deficit, muscle strength ≤ 4 points (as assessed by the Lovett scale).
- • 3. Time after the stroke before inclusion in the study is no more than 1 month.
- • 4. No severe deficit in cognitive functions.
- Exclusion Criteria:
- • 1. Patients with implanted ferromagnetic or other metal devices sensitive to a magnetic field in the head or neck area; cochlear implants; implanted neurostimulators, pacemakers, or drug delivery pumps.
- • 2. Complete aphasia or severe cognitive impairment.
- • 3. Taking tricyclic antidepressants, neuroleptics, or benzodiazepines.
- • 4. Previous skull fractures or other head injuries with loss of consciousness.
- • 5. History of epilepsy or seizures.
- • 6. Spasticity of the upper limb (Ashworth scale \>2 b.).
- • 7. Pregnancy
About Lithuanian University Of Health Sciences
The Lithuanian University of Health Sciences (LSMU) is a leading academic institution dedicated to advancing health sciences through innovative research and education. With a strong emphasis on interdisciplinary collaboration, LSMU conducts clinical trials aimed at improving patient outcomes and enhancing healthcare practices. The university's commitment to rigorous scientific inquiry is complemented by its state-of-the-art facilities and a network of experienced professionals, making it a pivotal player in the field of medical research in Lithuania and beyond. Through its clinical trials, LSMU strives to contribute valuable insights to the global medical community while fostering the next generation of healthcare leaders.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kaunas, , Lithuania
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials